Stephane Ducassou

15PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsMolecular targetsAdolescent healthPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Jan 05, 2026
Genomics of Long-Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study.

Mathilde Veneziano-Broccia, Gerard Michel, Jean-Hugues Dalle

|Nov 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.

Pablo Berlanga, Isabelle Aerts, Nadège Corradini

|Oct 22, 2024
Outcome of childhood ALK-positive anaplastic large cell lymphoma relapses: Real-life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children.

Victor Pereira, Maël Barthoulot, Nathalie Aladjidi

|Apr 23, 2024
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome.

Thomas Pincez, Helder Fernandes, Mony Fahd

|Mar 27, 2023
Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B-acute lymphoblastic leukaemia.

C Collignon, C Domenech, S Ducassou

Pageof 3

Frequent Collaborators

4 joint publications

Arnaud Petit

4 joint publications

Nathalie Aladjidi

3 joint publications

Birgit Geoerger

2 joint publications

Nicolas André